ALLOGENE THERAPEUTICS, INC. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-24.2% -$133M
$416M
Current Assets↓-15.0% -$46M
$258M
Cash & Equivalents↓-31.3% -$24M
$52M
ST Investments
—
Net PPE↓-15.4% -$13M
$73M
Intangibles
—
Total Liabilities↓-2.5% -$3M
$123M
Current Liabilities↓-8.5% -$3M
$33M
Account Payables↓-20.8% -$1M
$4M
Stockholders Equity↓-30.7% -$130M
$293M
Retained Earnings↓-10.5% -$191M
$-2.01B
Operating Lease ROU Asset↓-11.8% -$5M
$40M
Operating Lease Liability↓-8.3% -$8M
$83M
Gross PP&E↓-2.2% -$3M
$145M
Accumulated Depreciation↑+16.0% +$10M
$73M
Contract Liability
$86K
Contract Liability (Current)
$86K